Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome

NCT03670160 is registered in ClinicalTrials.gov with University of Tennessee Medical Center as lead sponsor.

NCT NCT03670160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03670160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clonidine Versus Phenobarbital as Adjunctive Therapy for Neonatal Abstinence Syndrome
Lead sponsor
University of Tennessee Medical Center
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2018
Completion date
May 31, 2020
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal abstinence syndrome